• 09-Apr-2020

    Kazia CEO, Dr James Garner discusses the recent positive interim data from the phase II trial of paxalisib in glioblastoma, COVID-19 and the company's recent capital raising

  • 26-Jun-2019

    Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2019 Gold Coast Investment Showcase

  • 15-Apr-2019

    Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the Wholesale Investor Emergence event in Brisbane.

  • 11-Jul-2018

    Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2018 Gold Coast Investment Showcase.

  • 06-Apr-2018

    Dr James Garner speaks with CommSec re our GDC-0084 Phase II trial start.

  • 29-Mar-2018

    NDF Research Senior Analyst Stuart Roberts interviews Kazia Therapeutics CEO Dr James Garner as the GDC-0084 phase II trial launches in the US.

  • 30-Nov-2017

    CommSec interview re our new name, Kazia Therapeutics and our clinical trial progress.

  • 04-Jul-2017

    CommSec Executive Series interviews CEO Dr James Garner on benefits of new business model for patients

  • 19-May-2017

    ASX CEO Session interview with FNN

  • 1-May-2017

    Dr James Garner, CEO, speaks to Canary Networks investment forum